Xu, Mu
Lin, Ziqiang
Siegel, Carole E. http://orcid.org/0000-0002-7460-788X
Laska, Eugene M.
Abu-Amara, Duna
Genfi, Afia
Newman, Jennifer
Jeffers, Michelle K.
Blessing, Esther M.
Flanagan, Steven R.
Fossati, Silvia http://orcid.org/0000-0002-2047-222X
Etkin, Amit
Marmar, Charles R.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism
Article History
Received: 21 November 2022
Revised: 16 December 2022
Accepted: 21 December 2022
First Online: 21 February 2023
Competing interests
: C.R.M has received research and clinical program funding from National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute of Mental Health (NIMH). Department of Defense (DoD), U.S. Army Medical Research & Acquisition Activity (USAMRA), U.S. Army Telemedicine & Advanced Technology Research Center (TATRC), Steven & Alexandra Cohen Foundation, Cohen Veterans Bioscience (CVB). Cohen Veterans Network (CVN), Robin Hood Foundation. McCormick Foundation, Home Depot Foundation, Bank of America Foundation, Brockman Foundation, City of New York, has served as a PTSD Fellow for the George W. Bush Institute and is serving on the Clinical Science Advisory Group for Otsuka Pharmaceuticals. A.E.is the founder and owns equity in Alto Neuroscience, has consulted for and owns equity in Akili Interactive and Mindstrong Health, and has consulted for Brainsway, Cervel, Takaeda, Posit, Acadia, Otsuka, Lundbeck, and Janssen. A.E. received a grant from Brain Resource and is a paid editor at Neuropsychopharmacology. A.E. and C.R.M. have a pending patent (WO2017172487A1) entitled “Detecting or treating post-traumatic stress syndrome.” The other authors report no financial relationships with commercial interests.
: The investigators have adhered to the policies for the protection of human subjects as prescribed in AR 70–25 and the IRBs of the NYU Grossman School of Medicine and Stanford University. Informed consent was obtained from all subjects.